AMY BURRELL

• Directed 20+ international R&D projects supporting GMP clinical manufacturing, increasing alignment with strategic objectives and enhancing team proficiency by 30%
• Spearheaded the development and integration of novel bioinformatics tools for cell therapy platforms, improving method efficacy and cutting production timelines by 50%
• Authored and implemented 30+ technical SOPs, IQ/OQ/PQ documents, and risk assessments, ensuring compliance with regulatory frameworks and optimizing processes
• Collaborated with QA, QC, and tech operation teams to resolve 20+ critical challenges, mitigating costly batch failures and saving over €2M in production expenses
• Improved cell isolation protocols, achieving a 20% increase in target cell recovery and enhancing cell viability by 25%

Key Achievements:

• Directed, developed, and implemented a novel GMP cell sorter across 3 cell therapy platforms in liaison with the supplier, addressing customer-specific technical needs pre-launch.
• Developed and delivered comprehensive training materials for cutting-edge biotechnologies to French and Dutch operators, achieving expert knowledge levels at 2 key manufacturing sites.

• Led the development and validation of 2 next-generation sequencing assays for epigenetics, increasing lab capacity for precision genomic analysis
• Completed 100+ high-precision workflows, including single-cell sequencing (10x Genomics) and CRISPR editing, shortening project timelines by 20%
• Managed and mentored a team of 10+ technicians, boosting work efficiency by 25% and ensuring data consistency across projects
• Negotiated supplier agreements for lab resources, reducing costs by €50K while securing high-quality materials
• Organized the logistics for 5 clinical sites’ biological samples weekly, ensuring compliance with ethical regulations

Key Achievements:

• Initiated cross-faculty collaborations that resulted in 3 new R&D projects, expanding the institution’s research portfolio

• Successfully processed and managed over 500 biological samples for GWAS/MWAS projects, streamlining storage systems and achieving 98% accuracy
• Conducted monthly qPCR assays and sequencing for MND screening, delivering results with 100% adherence to project timelines
• Developed data management protocols that increased lab throughput by 15% and reduced errors in sensitive data handling
• Trained junior team members, reducing onboarding workloads for senior staff by 40%

Key Achievements:

• Improved operational efficiency by standardizing solution preparation and sample storage, reducing processing downtime by 25%